Future studies will need to delineate the interplays among PR55α, p53, and p16 in the maintenance of cellular homeostasis or induction of cellular senescence, as well as how the dysregulation of these pathways promotes cancer or aging. This evidence concerns the gene CDKN2A and cancer.